Highmark Commercial Medical Policy in West Virginia

Section: Surgery
Number: S-66
Topic: Minimally Invasive Direct Coronary Artery Bypass Graft Surgery
Effective Date: September 26, 2011
Issued Date: September 26, 2011
Date Last Reviewed: 04/2011

General Policy Guidelines

Indications and Limitations of Coverage

Minimally invasive direct coronary artery bypass graft surgery (MIDCAB)(procedure codes S2205, S2206, S2207, S2208, S2209) may be considered medically necessary for the treatment of atherosclerosis. 

MIDCAB performed for other conditions is considered not medically necessary. A participating, preferred, or network provider cannot bill the member for the denied service unless the provider has given advance written notice, informing the member that the service may be deemed not medically necessary and providing an estimate of the cost. The member must agree in writing to assume financial responsibility, in advance of receiving the service. The signed agreement should be maintained in the provider's records.

Minimally invasive coronary artery surgery may involve other surgical techniques that include the use of robotic surgical systems. Other techniques for minimally invasive coronary artery bypass graft surgery, that can include the use of robotics and are not performed under direct visualization, are experimental/ investigational and therefore, non-covered. There is insufficient evidence to conclude that techniques that can include the use of robotics and are not performed under direct visualization, provide comparable outcomes to conventional open surgical procedure. A participating, preferred, or network provider can bill the member for the non-covered service. As there isn't a specific procedure code or codes to define other techniques for minimally invasive coronary artery bypass graft surgery, that can include the use of robotics and are not performed under direct visualization, claims for these services should be billed utilizing the not otherwise classified code 33999 with the description of the service noted on the claim descriptor for this NOC code.

Please refer to Medical Policy Bulletin, M-50, for additional information on robotic surgery.

Place of Service: Inpatient

Description

There are currently variations on techniques that are classified as “minimally invasive” coronary artery bypass graft (CABG) surgery. The surgery can be done under direct vision, with a mini-sternotomy or a mini-thoracotomy approach. These types of direct procedures have been termed minimally invasive direct coronary artery bypass (MIDCAB). MIDCAB is performed without cardiopulmonary bypass by slowing the heart rate to 40 beats per minute to minimize motion in the surgical field. The performance of a coronary bypass on a beating heart increases the technical difficulty of the procedure, particularly in terms of the quality of the vessel anastomosis. In MIDCAB, the predominant re-anastomosis performed uses the native internal mammary artery to bypass the left anterior descending (LAD) coronary artery. Bypass of the right coronary artery may also be possible in patients with suitable anatomy.

The surgery can also be performed endoscopically, whereby the internal structures are visualized on a video monitor, and the entire procedure is performed without direct visualization of the operative field. Cardiopulmonary bypass may or may not be used with this technique. Using this approach, theoretically, all sides of the heart can be approached. In many instances, only a single bypass of the LAD artery is performed, although multivessel bypass of the left and right coronary artery has been performed.


NOTE:
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Procedure Codes

33999S2205S2206S2207S2208S2209

Traditional Guidelines

Refer to General Policy Guidelines

FEP Guidelines

PPO Guidelines

Refer to General Policy Guidelines

Managed Care POS Guidelines

Refer to General Policy Guidelines

Publications

Provider News

06/2011, Highmark to cover Minimally Invasive Coronary Artery Bypass Surgery

References

Dogan S, Graubitz K, Aybek T, et al. How safe is the port access technique in minimally invasive coronary artery bypass grafting? Ann Thorac Surg. 2002;74(5):1537-43.

de Canniere D, Wimmer-Greinecker G, Cichon R, et al. Feasibility, safety, and efficacy of totally endoscopic coronary artery bypass grafting: multicenter European experience. J Thorac Cardiovasc Surg. 2007;134(3):710-6.

Aziz O, Rao C, Panesar SS, et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularization for isolated lesions of the left anterior descending artery. BMJ. 2007;334(7594):617-24.

Bainbridge D, Cheng D, Martin J, et al. Does off-pump or minimally invasive coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with percutaneous coronary intervention? A meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2007;133(3):623-31.

Jaffery Z, Kowalski M, Weaver WD, et al. A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur J Cardiothorac Surg. 2007;31(4):691-7.

Holzhey DM, et al. Seven-year follow-up after minimally invasive direct coronary artery bypass: experience with more than 1300 patients. Ann Thorac Surg. 2007 Jan;83(1):108-14.

Poston RS, et al. Comparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniques. Ann Surg. 2008 Oct;248(4):638-46.

Kettering K. Minimally invasive direct coronary artery bypass grafting” a meta-analysis. J Cardiovasc Surg (Torino). 2008;49(6):793-800.

Kappert U, Tugtekin SM, Cichon R, et al. Robotic totally endoscopic coronary artery bypass: a word of caution implicated by a five-year follow-up. J Thorac Cardiovasc Surg. 2008;135(4):857-62.

Bonatti J, Schachner T, Bonaros N, et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study. Cardiology. 2008;110(2):92-5.

Holzhey DM, et al. Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg. 2008 Dec; 86(6):1856-60.

Bonatti J,et al. Effectiveness and safety of total endoscopic left internal mammary artery bypass graft to the left anterior descending artery. Am J Cardiol. 2009 Dec 15;104(12):1684-8.

Thiele H, Neumann-Schniedewind P, Jacobs S, et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol. 2009;53(25):2324-31.

Kofidis T, Emmert MY, Paeschke HG, et al. Long-term follow-up after minimal invasive direct coronary artery bypass grafting procedure: a multi-factorial retrospective analysis at 1000 patient-years. Interact Cardiovasc Thorac Surg. 2009;9(6):990-4.

Shroyer AL, Grover FL, Hattler B, et al. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009;361(19):1827-37.

McGinn JT Jr. Minimally invasive coronary artery bypass grafting: dual-center experience in 450 consecutive patients. Circulation. 2009 Sep 15;120(11 Suppl):S78-84.

Karpuzoglu OE, et al. Comparison of minimally invasive direct coronary artery bypass and off-pump coronary artery bypass in single-vessel disease. Heart Surg Forum. 2009 Jan;12(1):E39-43.

Angelini GD, Culliford L, Smith DK, et al. Effects of on and off-pump coronary artery surgery on graft patency, survival, and health-related quality of life: long-term follow-up of 2 randomized controlled trials. J Thorac Cardiovasc Surg. 2009;137; 295-303.

Konety SH, Rosenthal GE, Vaughan-Sarrazin MS. Surgical volume and outcomes of off-pump coronary artery bypass graft surgery: does it matter? J Thorac Cardiovasc Surg. 2009;137:1116-1123.

Puskas JD, Mack JM, Smith CR. Letter to the editor. On-pump versus off-pump CABG. N Engl J Med. 2010;362(9):851.

Folliguet TA, et al. Robotically-Assisted Coronary Artery Bypass Grafting. Cardiol Res Pract. 2010;2010:175450. Epub 2010 Mar 18.

Halkos ME, Puskas JD. Off-pump coronary surgery: where do we stand in 2010? Curr Opin Cardiol. 2010 Nov;25(6):583-8.

Moller CH, Perko MJ, Lund JT, et al. No major differences in 30-day outcomes in high risk patients randomized to off-pump versus on-pump coronary artery bypass surgery. The Best Bypass Surgery Trial. Circulation. 2010;121:498-504.

Blue Cross and Blue Shield Association. Minimally Invasive Coronary Artery Bypass Graft Surgery. Medical Policy Reference Manual 7.01.62. Issued April, 2010.

View Previous Versions

[Version 004 of S-66]
[Version 003 of S-66]
[Version 002 of S-66]
[Version 001 of S-66]

Table Attachment

Text Attachment

Procedure Code Attachments

Diagnosis Codes

ICD-9 Diagnosis Codes

Covered Diagnosis Codes

414.00-414.07   

ICD-10 Diagnosis Codes

Glossary





This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Medical policies are designed to supplement the terms of a member's contract. The member's contract defines the benefits available; therefore, medical policies should not be construed as overriding specific contract language. In the event of conflict, the contract shall govern.

Medical policies do not constitute medical advice, nor the practice of medicine. Rather, such policies are intended only to establish general guidelines for coverage and reimbursement under Highmark West Virginia plans. Application of a medical policy to determine coverage in an individual instance is not intended and shall not be construed to supercede the professional judgment of a treating provider. In all situations, the treating provider must use his/her professional judgment to provide care he/she believes to be in the best interest of the patient, and the provider and patient remain responsible for all treatment decisions.

Highmark West Virginia retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark West Virginia. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.